Lamisil Once (Terbinafine)

Terbinafine inhibits the fungal enzyme squalene epoxidase, which blocks the synthesis of ergosterol, an essential component of the fungal cell membrane. The resulting accumulation of squalene and depletion of ergosterol disrupts membrane integrity, leading to fungal cell death and clearance of the infection.

The dosage of Lamisil Once is determined by the prescribing healthcare professional based on the type and extent of the infection, patient age, and other clinical factors. The prescriber will provide specific instructions on how much product to apply and how often.

Limited clinical data are available on the use of topical terbinafine during pregnancy or lactation. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using the product.

To order Lamisil Once, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Lamisil Once (terbinafine) belongs to the allylamine class, which generally achieves faster fungicidal activity compared with azole antifungals such as clotrimazole or miconazole. Allylamines target squalene epoxidase, while azoles inhibit lanosterol 14‑α‑demethylase; both result in fungal cell death but may differ in spectrum, speed of response, and resistance patterns.

Store Lamisil Once at room temperature below 25 °C, in its original packaging, protected from moisture and direct sunlight. Keep the container tightly closed when not in use and out of reach of children.

Apply a thin layer of the cream or gel to the affected skin area once daily, as directed by a healthcare professional. Gently rub it in until it disappears, and wash hands after application unless the hands are the treatment site.

Although uncommon, serious adverse reactions can include severe allergic responses such as anaphylaxis, Stevens‑Johnson syndrome, toxic epidermal necrolysis, and bullous dermatitis. Any signs of widespread rash, swelling, difficulty breathing, or severe skin blistering require immediate medical attention.

Individuals with a known hypersensitivity to terbinafine, other allylamines, or any component of the formulation should avoid using Lamisil Once. It is also contraindicated on extensive broken or inflamed skin where systemic absorption could be increased, and should be used with caution in patients with liver disease.